Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristi J Jones

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Neuromuscular Disorders : NMD|March 27, 2023
Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLaura Llansó, Ursula Moore, Carla Bolano-Diaz, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Frontiers in Neurology|January 4, 2021
Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With DysferlinopathyUrsula Moore, Marni Jacobs, Roberto Fernandez-Torron, et al.
Neuromuscular Disorders : NMD|February 21, 2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same diseaseUrsula Moore, Heather Gordish, Jordi Diaz-Manera, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathyUrsula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Muscle & Nerve|February 18, 2022
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal studyUrsula Moore, Roberto Fernandez-Torron, Marni Jacobs, et al.
Annals of Clinical and Translational Neurology|March 28, 2024
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing aloneRhett G Marchant, Samantha J Bryen, Melanie Bahlo, et al.
American Journal of Human Genetics|July 31, 2024
RNA variant assessment using transactivation and transdifferentiationEmmylou C Nicolas-Martinez, Olivia Robinson, Christian Pflueger, et al.
Neurology. Genetics|September 8, 2016
The Clinical Outcome Study for dysferlinopathy: An international multicenter studyElizabeth Harris, Catherine L Bladen, Anna Mayhew, et al.
Neurology. Genetics|July 31, 2025
Modeling of Dysferlinopathy (LGMDR2) Progression: A Longitudinal Fat Fraction AnalysisCarla Florencia Bolano-Diaz, Harmen Reyngoudt, Ian J Wilson, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Neuromuscular Disorders : NMD|March 27, 2023
Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI patternLaura Llansó, Ursula Moore, Carla Bolano-Diaz, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Frontiers in Neurology|January 4, 2021
Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With DysferlinopathyUrsula Moore, Marni Jacobs, Roberto Fernandez-Torron, et al.
Neuromuscular Disorders : NMD|February 21, 2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same diseaseUrsula Moore, Heather Gordish, Jordi Diaz-Manera, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathyUrsula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Muscle & Nerve|February 18, 2022
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal studyUrsula Moore, Roberto Fernandez-Torron, Marni Jacobs, et al.
Annals of Clinical and Translational Neurology|March 28, 2024
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing aloneRhett G Marchant, Samantha J Bryen, Melanie Bahlo, et al.
American Journal of Human Genetics|July 31, 2024
RNA variant assessment using transactivation and transdifferentiationEmmylou C Nicolas-Martinez, Olivia Robinson, Christian Pflueger, et al.
Neurology. Genetics|September 8, 2016
The Clinical Outcome Study for dysferlinopathy: An international multicenter studyElizabeth Harris, Catherine L Bladen, Anna Mayhew, et al.
Neurology. Genetics|July 31, 2025
Modeling of Dysferlinopathy (LGMDR2) Progression: A Longitudinal Fat Fraction AnalysisCarla Florencia Bolano-Diaz, Harmen Reyngoudt, Ian J Wilson, et al.
Pageof 5